CVS girds for battle over cholesterol drugs By: MarketWatch February 17, 2015 at 13:32 PM EST CVS Health Corp. warns that an oncoming class of new cholesterol drugs could heavily tax the nation’s health-care system. Read More >> Related Stocks: Amgen CVS Health Corp Gilead Sciences Pfizer Regeneron Pharmaceuticals Sanofi-Aventis S.A. ADR